A fraction of circulating CD4+ T cells from the patient was activated as evidenced by their increased STAT5 phosphorylation compared to circulating CD4+ T cells from pediatric IBD patients at baseline (Fig. 1h). Here, CD4 is linked to inflammatory bowel disease.